Unravelling essential key events in mitochondrial adverse outcome pathways

被引：0
|
作者：
van der Stel, W. [1 ]
Darici, S. [1 ]
van de Water, B. [1 ]
Danen, E. [1 ]
机构：
[1] Leiden Univ, Drug Discovery & Safety, Leiden, Netherlands
来源：
TOXICOLOGY LETTERS | 2018年 / 295卷
关键词：
D O I：
10.1016/j.toxlet.2018.06.869
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P16-23
引用
收藏
页码：S193 / S194
页数：2
相关论文
共 50 条
  • [1] Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways
    Villeneuve, Daniel L.
    Landesmann, Brigitte
    Allavena, Paola
    Ashley, Noah
    Bal-Price, Anna
    Corsini, Emanuela
    Halappanavar, Sabina
    Hussell, Tracy
    Laskin, Debra
    Lawrence, Toby
    Nikolic-Paterson, David
    Pallardy, Marc
    Paini, Alicia
    Pieters, Raymond
    Roth, Robert
    Tschudi-Monnet, Florianne
    TOXICOLOGICAL SCIENCES, 2018, 163 (02) : 346 - 352
  • [2] Adverse outcome pathways, key events, and radiation risk assessment
    Preston, R. Julian
    Ruhm, Werner
    Azzam, Edouard, I
    Boice, John D.
    Bouffler, Simon
    Held, Kathryn D.
    Little, Mark P.
    Shore, Roy E.
    Shuryak, Igor
    Weil, Michael M.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2021, 97 (06) : 804 - 814
  • [3] A systematic process for identifying key events for advancing the development of nanomaterial relevant adverse outcome pathways
    Halappanavar, Sabina
    Ede, James D.
    Shatkin, Jo Anne
    Krug, Harald F.
    NANOIMPACT, 2019, 15
  • [4] Machine-learning QSAR models to predict six key events of thyroid adverse outcome pathways
    de Lomana, M. G.
    Weber, A. G.
    Mathea, M.
    Birk, B.
    Landsiedel, R.
    Schleifer, K. J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (SUPPL 1) : 88 - 88
  • [5] A methodology for developing key events to advance nanomaterial-relevant adverse outcome pathways to inform risk assessment
    Halappanavar, Sabina
    Ede, James D.
    Mahapatra, Indrani
    Krug, Harald F.
    Kuempel, Eileen D.
    Lynch, Iseult
    Vandebriel, Rob J.
    Shatkin, Jo Anne
    NANOTOXICOLOGY, 2021, 15 (03) : 289 - 310
  • [6] Adverse outcome pathways
    Bolt, Hermann M.
    ARCHIVES OF TOXICOLOGY, 2017, 91 (12) : 4023 - 4024
  • [7] Adverse outcome pathways
    Hermann M. Bolt
    Archives of Toxicology, 2017, 91 : 4023 - 4024
  • [8] Unravelling mitochondrial pathways to Parkinson's disease
    Celardo, I.
    Martins, L. M.
    Gandhi, S.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (08) : 1943 - 1957
  • [9] A systematic process for identifying key events for advancing the development of nanomaterial relevant adverse outcome pathways (vol 15, 100178, 2019)
    Halappanavar, Sabina
    Ede, James D.
    Shatkin, Jo Anne
    Krug, Harald F.
    NANOIMPACT, 2021, 21
  • [10] Quantitative assessment of mitochondrial toxicity and downstream cellular perturbations in Adverse Outcome Pathways
    van de Water, B.
    TOXICOLOGY LETTERS, 2018, 295 : S32 - S32
12345